Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles. Transcript (txt) TBA News release copyright American Heart Association 2025
Thursday, February 13, 2025 at 7:30 PM Australian Eastern Daylight Time (Victoria).
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
BackgroundCardiac biomarkers improve risk prediction in patients with atrial fibrillation (AF). We recently demonstrated that the NFL (neuron‐specific protein neurofilament light chain) was associa…
Jennifer Rymer and Srihari Naidu say now is the time for both subspecialties to learn from one another, embrace new technologies, and fill some evidence…
The risk of incident heart failure (HF) after a myocardial infarction (MI) is up to six-fold higher than the risk of recurrent MI and the…
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the…
Internal documents and former company executives reveal how Cigna doctors reject patients’ claims without opening their files. “We literally click and submit,” one former company…
Quantum physics underlies technologies from the laser to the smartphone. The International Year of Quantum marks a century of scientific developments.
